| Brand Name | Votrient |
| Packaging Type | Bottle |
| Molecule | Pazopanib Hydrochloride |
| Generic Name | Pazopanib Hydrochloride 200mg |
| Manufactured By | Glaxosmithkline Pharmaceuticals |
| Quantity | 30 tablets |
| Form | Oral tablets |
| Country of Origin | India |
| Categories | Oncology |
Advanced renal cell carcinoma (RCC) patients can benefit from Votrient. Some locations name it pazopanib hydrochloride. TKIs block cancer cell growth signals. These medications include Votrient (200 mg tablet). Votrient is taken once a day on an empty stomach one to two hours before or after meals. Medical history, condition, and therapy response determine dosage.
Votrient Pazopanib Hydrochloride 200mg Tablets constitute a major advance in advanced renal cell carcinoma treatment. Even while it gives people hope, doctors must monitor its use to ensure no negative effects and optimal treatment. To know more about what is Votrient Pazopanib, keep reading.
Introduction To Votrient Pazopanib Hydrochloride 200mg Tablets
Strong drug Votrient Tablets with Pazopanib Hydrochloride are mostly given to advanced soft tissue sarcoma and renal cell carcinoma patients. Renal cell carcinoma, a fast-growing kidney malignancy, requires votrient. Votrient's main component, Pazopanib Hydrochloride, stops tumor blood vessel formation. Signaling pathway disruption prevents tumor and blood vessel development.
The 200 mg pill design simplifies portion control, helping patients adhere to treatment. Votrient is taken orally once a day with or without food as advised by a doctor. Hair color changes, sickness, high blood pressure, diarrhea, and weariness are side effects. Blood pressure, liver, and thyroid function must be checked periodically during treatment to detect side effects and maintain patient safety. Therapeutic response and tolerance determine dosage changes. Therefore, patients should check their medical history and health before using them.
How Does Votrient Pazopanib Hydrochloride 200mg Tablets Works
The cancer medication Votrient is 200 mg of Pazopanib Hydrochloride Tablets. This potent inhibitor targets soft tissue sarcoma and renal cell cancer. The drug targets many kinases, but VEGFR, PDGFR, and KIT are especially critical for cancer and blood vessel growth. It also targets other kinases. VEGFR blockade stops tumor angiogenesis, a crucial step in growth. It inhibits PDGFR, making cancer stromal cell division and movement tougher. Blocking KIT targets cancer stem cells to decrease tumor growth and spread.
Votrient Pazopanib Hydrochloride 200mg Tablets - Uses
Votrient 200mg is an essential treatment for cancer and related diseases. Its major function is to prevent cancer cells from proliferating and prevent tumors from growing new blood vessels. Votrient has numerous essential uses, including treating advanced kidney cancer. The medicine has reduced illness and increased survival.
Pazopanib Uses inhibits tumor growth and improves chemotherapy for advanced ovarian cancer patients. It targets cancer angiogenesis proteins, stopping the tumor from generating blood, which is essential for growth. Finally, Votrient Pazopanib Hydrochloride 200mg Tablets, a popular cancer medicine, helps ovarian, soft tissue sarcoma, and renal cell carcinoma patients.
Votrient Pazopanib Hydrochloride 200mg Tablets - Dosage
Votrient, Pazopanib 200mg tablets, treats advanced renal cell carcinoma. Taking 800 mg of Votrient once a day without meals and at least one to two hours before or after a meal is recommended. Take the pills whole with a glass of water, not crushed.
Based on tolerance, reactivity, and other health issues or medicines, patients may need to modify their dose. Some doctors recommend starting with 400 mg and gradually increasing it as Tolerance builds. Healthcare experts must periodically check on Votrient therapy patients to assess efficacy and manage adverse effects. Tell your doctor promptly if you have any side effects and take your prescription as advised. Patients must follow their dosing schedule to optimize Votrient advantages and minimize side effects. Votrient dosage and frequency are determined by your doctor.
Other Dosage of Votrient Pazopanib Hydrochloride 200mg Tablets
- Cizumab 100mg Injection
- Cladrim 10mg Injection
- Clokeran 2mg Tablets
- Cosalon Tablets
- Crizalk 250 mg Capsules
- Cycloxan 50mg Tablets
- Enzamide 40 mg Capsules
- Doxorex 10 MG injection
- Doxorex 50 MG injection
- Hertab 250 mg tablets
- Thalix 50 MG capsules
- Votrient 200 MG tablets
Votrient Pazopanib Hydrochloride 200mg Tablets - Side Effects and Precautions
Votrient, which contains 200 mg Pazopanib Hydrochloride pills, treats certain malignancies. However, it has warnings and side effects like any drug. Diarrhea, vomiting, and nausea are common adverse effects. Strength loss, taste alteration, and skin tone change are other negative effects. High blood pressure can cause headaches, weakness, and vision problems. Nosebleeds and simple bruising may indicate bleeding.
Major adverse effects include liver diseases that include yellowing skin, eyes, urine, and stomach discomfort.
Votrient Pazopanib Hydrochloride 200mg Tablets vs. Other Medicines
Comparing Votrient Pazopanib Hydrochloride 200mg Tablets with Sutent (Sunitinib Malate):
| Feature | Votrient Pazopanib Hydrochloride 200mg Tablets | Sutent (Sunitinib Malate) |
| Brand Names | Votrient | Sutent |
| Dosage Form | Oral tablet | Oral capsule |
| Typical Dosage | 800mg | 50mg |
| Onset of Action | 2-4 weeks | 2-4 weeks |
| Duration of Treatment | Continuous until disease progression or unacceptable toxicity | Cyclical (typically 6-week cycles) |
Check Votrient Pazopanib Hydrochloride 200mg Tablets at Indogenmed and order the tablets at a low cost with secure packaging now.
FAQ's of Votrient Pazopanib Hydrochloride 200mg Tablets
